RLJP leader Pashupati Kumar Paras has quit the NDA alliance due to alleged mistreatment by NDA members. He claims the ...

Rashtriya Lok Janshakti Party chief Pashupati Kumar Paras exited the BJP-led NDA, citing neglect and injustice towards his ...

UPSC CDS 1, NDA/NA 1 2025 Exam to be held today, April 13, 2025. Check important guidelines for candidates appearing for the ...

The RLJP, established by Paras in 2021 after a split from the Lok Janshakti Party, faced what it perceived as a lack of proper recognition by the BJP and JDU leadership in Bihar, particularly during ...

Former Union Minister Pashupati Kumar Paras on Monday announced that his party – Rashtriya Lok Janshakti Party – was no ...

JD(U) national spokesperson Rajeev Ranjan Prasad asserted that the ruling alliance faces no crisis over its chief ministerial face in Bihar, which is scheduled to go to polls later this year.

UPSC announces final results for NDA and NA Examination II, 2024. Imon Ghosh tops the merit list. Results available on ...

Pashupati Paras announced his Rashtriya Lok Janshakti Party's exit from BJP-led NDA at an event held in Patna on the occasion of Ambedkar Jayanti. Paras has, of late, been meeting RJD president Lalu ...

The results of the medical examination were not considered while preparing the merit list. The candidature of the qualified ...

The UPSC has released the admit cards for the National Defence Academy & Naval Academy Examination (I), 2025, also known as ...

JD(U) reaffirmed Nitish Kumar as the NDA's chief ministerial candidate for Bihar assembly elections, dismissing Haryana CM Nayab Singh Saini's suggestion of Samrat Choudhary as the leader.

Investing.com — Aldeyra Therapeutics, Inc. (NASDAQ: ALDX )股价暴跌75%，此前该公司收到美国食品药品监督管理局 (FDA)发出的完整回复函 (CRL)，涉及其新药申请 (NDA)中的reproxalap，该药物旨在治疗干眼症的症状和体征。FDA在信中指出，该NDA未能在充分且良好控制的研究中证明其对治疗与干眼相关的眼部症状的有效性。